ID

43594

Description

Study of Acid Reflux Therapy for Children With Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00604851

Lien

https://clinicaltrials.gov/show/NCT00604851

Mots-clés

Versions (2)
  1. 18/04/2016 18/04/2016 -
  2. 20/09/2021 20/09/2021 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Asthma NCT00604851

Anglais

Eligibility Asthma NCT00604851

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00604851
Criteria
Description

Criteria

6-16 years
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
asthma: physician diagnosed asthma, mathacholine pc20<16 mg/ml, treatment with a stable dose of daily inhaled corticosteroid equivalent to 200 micrograms/day of fluticasone or greater for 8 weeks or longer
Description

asthma

Type de données

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2]
C0040223
UMLS CUI [3]
C2065041
UMLS CUI [4]
C0430567
poor asthma control: use of beta-agonist for asthma symptoms twice/week or more, nocturnal awakening with asthma symptoms more than once per week, 2 or more emergency department, unscheduled physician visit, prednisone course, or hospitalizations for asthma in the past 12 months, score of 1.5 or greater on the juniper scale of recent asthma control
Description

poor asthma control

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2700379
UMLS CUI [1,3]
C2587213
UMLS CUI [2]
C4039704
UMLS CUI [3,1]
C2065041
UMLS CUI [3,2]
C0583237
UMLS CUI [4]
C0019993
absence of gerd symptoms: no symptoms clearly attributed to ger at the time of enrollment.
Description

gerd symptom

Type de données

boolean

Alias
UMLS CUI [1]
C2367776
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
surgery: previous anti-reflux or peptic ulcer surgery, previous tracheo-esophageal fistula repair
Description

prior surgery

Type de données

boolean

Alias
UMLS CUI [1]
C0744961
UMLS CUI [2]
C0399651
UMLS CUI [3]
C0749751
UMLS CUI [4]
C0472916
pulmonary function:fev1 <60% predicted normal as measured immediately before methacholine bronchoprovocation. methacholine bronchoprovocation limited to participants with an fev1 >70% of predicted in accordance with fda indication
Description

fev1

Type de données

boolean

Alias
UMLS CUI [1]
C0748133
UMLS CUI [2]
C0430567
other major chronic illnesses: any major chronic illness including but not limited to non-skin cancer, cystic fibrosis, bronchiectasis, myelomeningocele, sickle cell anemia, endocrine disease, congenital heart disease, congestive heart failure, stroke, severe hypertension, insulin-dependent diabetes mellitus, renal failure, liver disorders, immunodeficiency states, significant neurodevelopmental delay or behavioral disorders or other conditions that would interfere with participation in the study.
Description

comorbidity

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
medication use: anti-reflux medication (proton pump inhibitors, h2 blockers, bethanecol, metaclopromide) within 1 month; theophylline preparations, azoles, anti-coagulants, insulin, digitalis, any investigative drug within 2 months.
Description

medication use

Type de données

boolean

Alias
UMLS CUI [1]
C0746470
UMLS CUI [2]
C0358591
UMLS CUI [3]
C0019593
UMLS CUI [4]
C0053526
UMLS CUI [5]
C0025853
UMLS CUI [6]
C0039771
UMLS CUI [7]
C0004504
UMLS CUI [8]
C0003280
UMLS CUI [9]
C0021641
UMLS CUI [10]
C0304520
UMLS CUI [11]
C0013230
drug allergy: previous adverse effects from lansoprazole, other proton pump inhibitors or methacholine challenge.
Description

drug allergy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0050940
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0358591
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0430567
non-adherence: inability or unwillingness of the legal guardian to provide consent or inability or unwillingness of the child to provide assent. inability to swallow study medication. inability to perform baseline measurements. less than 80% completion of screening period diaries. inability to contact by telephone. intention to move out of the areqa within 6 months. no pregnancy.
Description

non-adherence

Type de données

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2]
C0021430
Retour au début de la page

Similar models

Eligibility Asthma NCT00604851

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00604851
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
age
Item
6-16 years
boolean
C0001779 (UMLS CUI [1])
asthma
Item
asthma: physician diagnosed asthma, mathacholine pc20<16 mg/ml, treatment with a stable dose of daily inhaled corticosteroid equivalent to 200 micrograms/day of fluticasone or greater for 8 weeks or longer
boolean
C0004096 (UMLS CUI [1])
C0040223 (UMLS CUI [2])
C2065041 (UMLS CUI [3])
C0430567 (UMLS CUI [4])
poor asthma control
Item
poor asthma control: use of beta-agonist for asthma symptoms twice/week or more, nocturnal awakening with asthma symptoms more than once per week, 2 or more emergency department, unscheduled physician visit, prednisone course, or hospitalizations for asthma in the past 12 months, score of 1.5 or greater on the juniper scale of recent asthma control
boolean
C0004096 (UMLS CUI [1,1])
C2700379 (UMLS CUI [1,2])
C2587213 (UMLS CUI [1,3])
C4039704 (UMLS CUI [2])
C2065041 (UMLS CUI [3,1])
C0583237 (UMLS CUI [3,2])
C0019993 (UMLS CUI [4])
gerd symptom
Item
absence of gerd symptoms: no symptoms clearly attributed to ger at the time of enrollment.
boolean
C2367776 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
prior surgery
Item
surgery: previous anti-reflux or peptic ulcer surgery, previous tracheo-esophageal fistula repair
boolean
C0744961 (UMLS CUI [1])
C0399651 (UMLS CUI [2])
C0749751 (UMLS CUI [3])
C0472916 (UMLS CUI [4])
fev1
Item
pulmonary function:fev1 <60% predicted normal as measured immediately before methacholine bronchoprovocation. methacholine bronchoprovocation limited to participants with an fev1 >70% of predicted in accordance with fda indication
boolean
C0748133 (UMLS CUI [1])
C0430567 (UMLS CUI [2])
comorbidity
Item
other major chronic illnesses: any major chronic illness including but not limited to non-skin cancer, cystic fibrosis, bronchiectasis, myelomeningocele, sickle cell anemia, endocrine disease, congenital heart disease, congestive heart failure, stroke, severe hypertension, insulin-dependent diabetes mellitus, renal failure, liver disorders, immunodeficiency states, significant neurodevelopmental delay or behavioral disorders or other conditions that would interfere with participation in the study.
boolean
C0009488 (UMLS CUI [1])
medication use
Item
medication use: anti-reflux medication (proton pump inhibitors, h2 blockers, bethanecol, metaclopromide) within 1 month; theophylline preparations, azoles, anti-coagulants, insulin, digitalis, any investigative drug within 2 months.
boolean
C0746470 (UMLS CUI [1])
C0358591 (UMLS CUI [2])
C0019593 (UMLS CUI [3])
C0053526 (UMLS CUI [4])
C0025853 (UMLS CUI [5])
C0039771 (UMLS CUI [6])
C0004504 (UMLS CUI [7])
C0003280 (UMLS CUI [8])
C0021641 (UMLS CUI [9])
C0304520 (UMLS CUI [10])
C0013230 (UMLS CUI [11])
drug allergy
Item
drug allergy: previous adverse effects from lansoprazole, other proton pump inhibitors or methacholine challenge.
boolean
C0020517 (UMLS CUI [1,1])
C0050940 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0358591 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0430567 (UMLS CUI [3,2])
non-adherence
Item
non-adherence: inability or unwillingness of the legal guardian to provide consent or inability or unwillingness of the child to provide assent. inability to swallow study medication. inability to perform baseline measurements. less than 80% completion of screening period diaries. inability to contact by telephone. intention to move out of the areqa within 6 months. no pregnancy.
boolean
C1321605 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial